Skip to content

Friday, March 31, 2023

Latest:

“I” before “E” in medicine and VIP patient access
And the 2022 ATC Core of the Year Award goes to…
Baylor surgeons aim to improve colorectal cancer care through research
Uncovering drivers of glioma-related epilepsy
Debating Diets: What is the pescatarian diet?

Baylor College of Medicine Blog Network

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

bad cholesterol

Clinical trial finds that oral drug MK-0616 substantially reduces ‘bad’ cholesterol

March 14, 2023March 14, 2023atherosclerosis, bad cholesterol, Cardiovascular Disease, LDL-cholesterol, MK-0616, PCSK9 inhibitor, Research

MK-016 could offer another potential option to achieve guideline-recommended LDL-C levels resulting in reduction of cardiovascular risk.

From the Labs Image of the Month

From the Labs: a transparent heart

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951